Log In
Print this Print this

BRAF V600E oncogene mutation assay, Trovera BRAF

  Manage Alerts
Collapse Summary General Information
Company Trovagene Inc.
DescriptionNon-invasive molecular diagnostic to detect the BRAF V600E mutation in urinary cell-free DNA (cfDNA)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Biomarkers and companion diagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect BRAF V600E mutations in cancer patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today